logo
  • About Us
    • Company Overview
    • Vision / Mission / Values
    • Leadership
    • Clinical Advisory Board
    • Partnering
  • Our Approach
    • Technologies
    • Manufacturing
    • Publications
  • Pipeline
    • Pipeline
      • Autologous CAR-T
      • Allogeneic CAR-T
    • Expanded Access
  • Investors
    • Announcements
    • Corporate Governance
    • Corporate Deck & Presentations
      • Webcasts
      • Presentations
    • Financial Reports
    • Listing Documents
    • IR Contact
  • Newsroom
  • Careers
    • Join Us
  • Contact Us
EN 简
  • About Us
    • Company Overview
    • Vision / Mission / Values
    • Leadership
    • Clinical Advisory Board
    • Partnering
  • Our Approach
    • Technologies
    • Manufacturing
    • Publications
  • Pipeline
    • Pipeline
      • Autologous CAR-T
      • Allogeneic CAR-T
    • Expanded Access
  • Investors
    • Announcements
    • Corporate Governance
    • Corporate Deck & Presentations
      • Webcasts
      • Presentations
    • Financial Reports
    • Listing Documents
    • IR Contact
  • Newsroom
  • Careers
    • Join Us
  • Contact Us

Newsroom

  • Home -
  • Newsroom -
18
Sep 2025
CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025
Sep 18, 2025
12
Sep 2025
Preliminary Clinical Data of Allogeneic CD19/CD20 CAR-T Product for Mantle Cell Lymphoma Reported at Academic Conference
Sep 12, 2025
15
Aug 2025
CARsgen Therapeutics Announces 2025 Interim Results
Aug 15, 2025
22
Jul 2025
ESMO Preview | CARsgen to Present Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025
Jul 22, 2025
14
Jul 2025
CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO
Jul 14, 2025
26
Jun 2025
CARsgen Therapeutics Announces NDA Acceptance of Satri-cel by China’s NMPA
Jun 26, 2025
25
Jun 2025
CARsgen Therapeutics Submits New Drug Application for Satri-cel to China’s NMPA
Jun 25, 2025
16
Jun 2025
CARsgen Presents Results of GPRC5D CAR-T CT071 at EHA 2025
Jun 16, 2025
02
Jun 2025
CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting
Jun 02, 2025
28
May 2025
CARsgen’s Satri-cel Granted Priority Review by the NMPA
May 28, 2025
  • 1
  • 2
  • ...
  • 11
Wechat
qr
Linkedin
  • About Us
    • Company Overview
    • Vision / Mission / Values
    • Leadership
    • Clinical Advisory Board
    • Partnering
  • Our Approach
    • Technologies
    • Manufacturing
    • Publications
  • Pipeline
    • Pipeline
    • Expanded Access
  • Investors
    • Announcements
    • Corporate Governance
    • Corporate Deck & Presentations
    • Financial Reports
    • Listing Documents
    • IR Contact
  • Newsroom
  • Careers
    • Join Us
  • Contact Us
Privacy Policy Terms of Use Developed by Euroland IR
Copyright ©2021-2025 CARsgen Therapeutics Holdings Limited